Acute myelogenous leukemia patients are at low risk for invasive fungal infections after high-dose cytarabine consolidations and thus do not require prophylaxis

Grant Lewis, Patricia Hall, Nihal Eisa, David Deremer, Robin Dobbins, Mohamed El-Geneidy, Anand Jillella, Celalettin Ustun

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'Acute myelogenous leukemia patients are at low risk for invasive fungal infections after high-dose cytarabine consolidations and thus do not require prophylaxis'. Together they form a unique fingerprint.

Medicine & Life Sciences